Peppermint and Paclitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Peppermint (peppermint) and Paclitaxel (paclitaxel). Common drug interactions include nausea among females and orbital oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Peppermint and Paclitaxel. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Peppermint?

Peppermint has active ingredients of peppermint. eHealthMe is studying from 1,327 Peppermint users. Check the latest studies of Peppermint.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.



On Jul, 18, 2026

49 people who take Peppermint and Paclitaxel together, and have interactions are studied.

Peppermint and Paclitaxel drug interactions.

What are the common drug interactions of Peppermint and Paclitaxel, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pain
  4. Skin ulcer
  5. Enteritis (inflammation of the small intestine)
  6. Hypokalaemia (low potassium)
  7. Post procedural diarrhoea
  8. Diarrhoea
  9. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  10. Abdominal pain

male:

  1. Orbital oedema (swelling of orbit)

What are the common drug interactions of Peppermint and Paclitaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Nail disorder (disease of nail)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pain
  4. Skin ulcer
  5. Hypokalaemia (low potassium)
  6. Post procedural diarrhoea
  7. Nausea (feeling of having an urge to vomit)
  8. Diarrhoea
  9. Abdominal pain
  10. Alopecia (absence of hair from areas of the body)

60+:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Enteritis (inflammation of the small intestine)
  3. Orbital oedema (swelling of orbit)

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 37 people, 75.51%
  2. Stomatitis (inflammation of mucous membrane of mouth): 20 people, 40.82%
  3. Rashes (redness): 20 people, 40.82%
  4. Oral Herpes (viral infection of mouth): 20 people, 40.82%
  5. Diarrhea: 11 people, 22.45%
  6. Pain: 9 people, 18.37%

* Approximation only. Some reports may have incomplete information.

Do you take Peppermint and Paclitaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Peppermint and Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Peppermint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Peppermint and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paclitaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on peppermint and paclitaxel (the active ingredients of Peppermint and Paclitaxel, respectively), and Peppermint and Paclitaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: